FDA Inspection 999138 — Biotest Pharmaceuticals Corporation
The FDA completed an inspection of Biotest Pharmaceuticals Corporation on October 13, 2016 in Melbourne, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 13, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Melbourne, FL (United States)